SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IN PATIENTS RANDOMIZED INTO A TRIAL OF IFN-ALPHA VERSUS CHEMOTHERAPY - NO SIGNIFICANT ADVERSE EFFECT OF PROLONGED IFN-ALPHA ADMINISTRATION

Citation
P. Shepherd et al., SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IN PATIENTS RANDOMIZED INTO A TRIAL OF IFN-ALPHA VERSUS CHEMOTHERAPY - NO SIGNIFICANT ADVERSE EFFECT OF PROLONGED IFN-ALPHA ADMINISTRATION, Blood, 86(10), 1995, pp. 363-363
Citations number
NO
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
86
Issue
10
Year of publication
1995
Supplement
1
Pages
363 - 363
Database
ISI
SICI code
0006-4971(1995)86:10<363:SAABT(>2.0.ZU;2-G